PT Kalbe Farma Tbk. (FRA:LCLA)
Germany flag Germany · Delayed Price · Currency is EUR
0.0545
-0.0010 (-1.80%)
At close: Dec 5, 2025

PT Kalbe Farma Tbk. Company Description

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia.

The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments.

The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.

It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services.

The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk.
CountryIndonesia
Founded1966
IndustryPharmaceutical Preparations
Employees12,903
CEOBernadette Ruth Setiady

Contact Details

Address:
Gedung KALBE
Jakarta, 10510
Indonesia
Phone62 21 4287 3888
Websitekalbe.co.id

Stock Details

Ticker SymbolLCLA
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyIDR
SIC Code2834

Key Executives

NamePosition
Bernadette Ruth SetiadyChief Executive Officer